Novel сoronavirus infectious disease COVID-19: features of comprehensive cardiac and respiratory rehabilitation

Cover Page

Cite item

Full Text

Abstract

In the Consensus of experts from Russian societies, issues of comprehensive medical rehabilitation of patients with a new coronavirus infection are being discussed. Coronavirus Disease 2019 (COVID-19) is a contagious infectious disease that can cause respiratory, cardiac, motor, metabolic, neurocognitive and mental disorders, i.e. multiple organ dysfunction. Patients who survived COVID-19, especially after a severe course, face serious psychological and physical problems, post-traumatic stress, cognitive dysfunction, nutritional deficiencies and exacerbation of concomitant chronic diseases. Some patients, regardless of the severity of the coronavirus infection, have a long-term course of disease ("chronic COVID", "long-term COVID"). There is evidence of the development of "post-COVID-19 syndrome". In this regard, patients with COVID-19 need rehabilitation. The Consensus of experts from Russian societies provides general principles, stages and aspects of medical rehabilitation after COVID-19, indications and contraindications for rehabilitation interventions. The Consensus includes recommendations on comprehensive cardiac and respiratory rehabilitation, as well as the features of the rehabilitation of patients with different clinical course of COVID-19 within the framework of the national three-stage medical rehabilitation system.

About the authors

Marina G. Bubnova

National Research Center for Therapy and Preventive Medicine

Author for correspondence.
Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0003-2250-5942

D. Sci. (Med.), Prof., National Research Center for Therapy and Preventive Medicine

Russian Federation, Moscow

Evgenii V. Shliakhto

Almazov National Medical Research Centre

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0003-2929-0980

D. Sci. (Med.), Prof., Acad. RAS, Almazov National Medical Research Centre

Russian Federation, Saint Petersburg

David M. Aronov

National Research Center for Therapy and Preventive Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0003-0484-9805

D. Sci. (Med.), Prof., National Research Center for Therapy and Preventive Medicine

Russian Federation, Moscow

Andrei S. Belevskii

Pirogov Russian National Research Medical University

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0001-6050-724X

D. Sci. (Med.), Prof., Pirogov Russian National Research Medical University

Russian Federation, Moscow

Marina I. Gerasimenko

Russian Medical Academy of Continuous Professional Education

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-1741-7246

D. Sci. (Med.), Prof., Russian Medical Academy of Continuous Professional Education

Russian Federation, Moscow

Mariia G. Glezer

Sechenov First Moscow State Medical University (Sechenov University)

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-0995-1924

D. Sci. (Med.), Prof., Sechenov First Moscow State Medical University

Russian Federation, Moscow

Mikhail N. Gordeev

Milton Erickson Institute; Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Email: mbubnova@gnicpm.ru

D. Sci. (Med.), D. Sci. (Psychol.), Prof., Milton Erickson Institute, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Russian Federation, Moscow; Moscow

Oksana M. Drapkina

National Research Center for Therapy and Preventive Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-4453-8430

D. Sci. (Med.), Prof., Corr. Memb. RAS, National Research Center for Therapy and Preventive Medicine

Russian Federation, Moscow

Galina E. Ivanova

Pirogov Russian National Research Medical University; Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Email: mbubnova@gnicpm.ru

D. Sci. (Med.), Prof., Pirogov Russian National Research Medical University, Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Russian Federation, Moscow; Moscow

David G. Ioseliani

Sechenov First Moscow State Medical University (Sechenov University)

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0001-6425-7428

D. Sci. (Med.), Prof., Acad. RAS, Sechenov First Moscow State Medical University

Russian Federation, Moscow

Natalia S. Karamnova

National Research Center for Therapy and Preventive Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-8604-712X

Cand. Sci. (Med.), National Research Center for Therapy and Preventive Medicine

Russian Federation, Moscow

Elena D. Kosmacheva

Kuban State Medical University; Scientific Research Institute – Ochapovsky Regional Clinical Hospital №1

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0001-8600-0199

D. Sci. (Med.), Prof., Kuban State Medical University, Scientific Research Institute – Ochapovsky Regional Clinical Hospital №1

Russian Federation, Krasnodar; Krasnodar

Andrei V. Kuleshov

Respiratory Medicine Clinic “IntegraMed”

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0003-0658-4871

Cand. Sci. (Med.), Respiratory Medicine Clinic “IntegraMed”

Russian Federation, Moscow

Anastasiia A. Kukshina

Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-2290-3687

D. Sci. (Med.), Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Russian Federation, Moscow

Konstantin V. Liadov

Sechenov First Moscow State Medical University (Sechenov University); Multidisciplinary Medical Center “Lyadov Clinics”

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0001-6972-7740

D. Sci. (Med.), Prof., Acad. RAS, Sechenov First Moscow State Medical University

Russian Federation, Moscow; Khimki

Nadezhda P. Liamina

Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0001-6939-3234

D. Sci. (Med.), Prof., Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Russian Federation, Moscow

Natalia N. Meshcheriakova

Pirogov Russian National Research Medical University

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-1757-4137

Cand. Sci. (Med.), Pirogov Russian National Research Medical University

Russian Federation, Moscow

Marina R. Makarova

Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-1787-7015

Cand. Sci. (Med.), Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Russian Federation, Moscow

Dmitrii B. Nikitiuk

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-4968-4517

D. Sci. (Med.), Prof., Corr. Memb. RAS, Federal Research Center of Nutrition, Biotechnology and Food Safety

Russian Federation, Moscow

Igor N. Pasechnik

Central State Medical Academy of the President of the Russian Federation

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-8121-4160

D. Sci. (Med.), Prof., Central State Medical Academy of the President of the Russian Federation

Russian Federation, Moscow

Anna L. Persiianova-Dubrova

National Research Center for Therapy and Preventive Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-8508-5327

Cand. Sci. (Med.), National Research Center for Therapy and Preventive Medicine

Russian Federation, Moscow

Irena V. Pogonchenkova

Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0001-5123-5991

D. Sci. (Med.), Moscow Scientific and Practical Center of Medical Rehabilitation, Rehabilitation and Sports Medicine

Russian Federation, Moscow

Aleksei V. Svet

Pirogov City Clinical Hospital №1

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0003-2101-6936

Cand. Sci. (Med.), Pirogov City Clinical Hospital №1

Russian Federation, Moscow

Antonina V. Starodubova

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: mbubnova@gnicpm.ru

D. Sci. (Med.), Federal Research Center of Nutrition, Biotechnology and Food Safety

Russian Federation, Moscow

Viktor A. Tutel'ian

Federal Research Center of Nutrition, Biotechnology and Food Safety

Email: mbubnova@gnicpm.ru
ORCID iD: 0000-0002-4164-8992

D. Sci. (Med.), Prof., Acad. RAS, Federal Research Center of Nutrition, Biotechnology and Food Safety

Russian Federation, Moscow

References

  1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 48. World Health Organization. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4. Accessed: 22.03.2021.
  2. Brugliera L, Spina A, Castellazzi P, et al. Rehabilitation of COVID-19 patients. J Rehabil Med. 2020;52(4):jrm00046. doi: 10.2340/16501977-2678
  3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi: 10.1001/jama.2020.1585
  4. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г., и др. Международный регистр «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (AКТИВ SARS-CoV-2)»: анализ 1000 пациентов. Рос. кардиол. журн. 2020;25(11):4165 [Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. 2020;25(11):4165 (in Russian)]. doi: 10.15829/1560-4071-2020-4165
  5. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. doi: 10.1007/s00134-020-05991-x
  6. Глыбочко П.В., Фомин В.В., Авдеев С.Н., и др. Клиническая характеристика 1007 больных тяжелой SARS-CoV-2 пневмонией, нуждавшихся в респираторной поддержке. Клин. фармакол. тер. 2020;29(2):21-9 [Glybochko PV, Fomin VV, Avdeev SN, et al. Clinical characteristics of 1007 intensive care unit patients with SARS-CoV-2 pneumonia. Klinicheskaya farmakologiya i terapiya. 2020;29(2):21-9 (in Russian)]. doi: 10.32756/0869-5490-2020-2-21-29
  7. National Institute for Health and Care Excellence, Royal College of General Practitioners, Healthcare Improvement Scotland SIGN. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence, 2020. Available at: www.nice.org.uk/guidance/ng188. Accessed: 18.12.2020.
  8. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. doi: 10.1038/s41586-020-2012-7
  9. Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90. doi: 10.1007/s00134-020-05985-9
  10. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):1-10. doi: 10.1016/j.cell.2020.02.052
  11. Самсонова М.В., Черняев А.Л., Омарова Ж.Р., и др. Особенности патологической анатомии легких при COVID-19. Пульмонология. 2020;30(5):519-32 [Samsonova MV, Chernyaev AL, Omarova ZhR, et al. Features of pathological anatomy of lungs at COVID-19. Pul’monologiya. 2020;30(5):519-32 (in Russian)]. doi: 10.18093/0869-0189-2020-30-5-519-532
  12. Зайратьянц О.В., Самсонова М.В., Михалева Л.М., и др. Патологическая анатомия легких при COVID-19: атлас. Под ред. О.В. Зайратьянца. М.–Рязань: Рязанская областная типография, 2020 [Zairatyants OV, Samsonova MV, Mikhaleva LM, et al. Pathological anatomy of the lungs by COVID-19: atlas. Edited by O.V. Zairatyants. Moscow–Ryazan: Ryazan regional printing house, 2020 (in Russian)].
  13. Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. doi: 10.1016/j.rmed.2020.105941
  14. Pericàs JM, Hernandez-Meneses M, Sheahan TP, et al. COVID-19: from epidemiology to treatment. Eur Heart J. 2020;41(22):2092-112. doi: 10.1093/eurheartj/ehaa462
  15. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43. doi: 10.1001/jamaimternmed.2020.0994
  16. Parohan M, Yaghoubi S, Seraji A, et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416-24. doi: 10.1080/13685538.2020.1774748
  17. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. 2020. Available at: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance. Accessed: 20.03.2021.
  18. Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821-9. doi: 10.1093/eurheartj/ehaa388
  19. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3
  20. Chen R, Liang W, Jiang M, et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020;158(1):97-105. doi: 10.1016/j.chest.2020.04.010
  21. Hendren NS, Drazner MH, Bozkurt B, et al. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020;141(23):1903-14. doi: 10.1161/CIRCULATIONAHA.120.047349
  22. Guzik T, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-87. doi: 10.1093/cvr/cvaa106
  23. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230-2. doi: 10.1007/s00059-020-04909-z
  24. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-98. doi: 10.1007/s00134-020-06062-x
  25. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743-6. doi: 10.1111/jth.14869
  26. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. doi: 10.1016/j.thromres.2020.04.013
  27. Poissy J, Goutay J, Caplan M, et al. Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020;142(2):184-6. doi: 10.1161/CIRCULATIONAHA.120.047430
  28. Bansal M. Cardiovascular disease and COVID-19. Diabetes and Metab Syndr. 2020;14(3):247-50. doi: 10.1016/j.dsx.2020.03.013
  29. Hendren NS, Grodin JL, Drazner MH. Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019. J Card Fail. 2020;26(6):466-9. doi: 10.1016/j.cardfail.2020.05.006
  30. Cooper Jr LT. Myocarditis. N Engl J Med. 2009;360(15):1526-38. doi: 10.1056/NEJMra 0800028
  31. Barker-Davies RM, O’Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-59. doi: 10.1136/bjsports-2020-102596
  32. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. doi: 10.1001/jamaneurol.2020.1127
  33. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60. doi: 10.1056/NEJMc2009787
  34. Pérez CA. Looking ahead: The risk of neurologic complications due to COVID-19. Neurol Clin Pract. 2020;10(4):371-4. doi: 10.1212/CPJ.0000000000000836
  35. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296(2):E119-E120. doi: 10.1148/radiol.2020201187
  36. Toscano G, Palmerini F, Ravaglia S, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6. doi: 10.1056/NEJMc2009191
  37. Talan J. COVID-19: Neurologists in Italy to Colleagues in US: Look for Poorly-Defined Neurologic Conditions in Patients with the Coronavirus. Neurology Today, American Academy of Neurology. 2020. Available at: https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=920&fbclid=Iw. Accessed: 20.03.2021.
  38. British Geriatrics Society. COVID-19: Dementia and cognitive impairment. Available at: https://www.bgs.org.uk/resources/covid-19-dementia-and-cognitive-impairment. Accessed: 20.03.2021.
  39. Zhu S, Gao Q, Yang L, et al. Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China. PLoS ONE. 2020;15(12):e0243883. doi: 10.1371/journal.pone.0243883
  40. Xiang YT, Zhao YJ, Liu ZH, et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J Biol Sci. 2020;16(10):1741-4. doi: 10.7150/ijbs.45072
  41. Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020;158(6):1518-9. doi: 10.1053/j.gastro.2020.02.054
  42. Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-78. doi: 10.1016/S2468-1253(20)30126-6
  43. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi: 10.1056/NEJMoa2002032
  44. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 9 (26.10.2020). Министерство здравоохранения Российской Федерации. Режим доступа: https://www.rosminzdrav.ru/news/2020/26/10/14109-minzdrav-rossii-utverdil-7-versiyumetodicheskih-ekomendatsiy-po-lecheniyu-covid-19. Ссылка активна на 20.03.2021 [Temporary guidelines for Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 9 (26.10.2020) of the Ministry of health of the Russian Federation. Available at: https://www.rosminzdrav.ru/news/2020/26/10/14109-minzdrav-rossii-utverdil-7-versiyumetodicheskih-ekomendatsiy-po-lecheniyu-covid-19. Accessed: 20.03.2021 (in Russian)].
  45. Заболотских И.Б., Киров М.Ю., Лебединский К.М., и др. Анестезиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID-19. Методические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов». Вестник интенсивной терапии им. А.И. Салтанова. 2020;S1:9-120 [Zabolotskikh IB, Kirov MYu, Lebedinskii KM, et al. Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines. Annals of Critical Care. 2020;S1:9-120 (in Russian)]. doi: 10.21320/1818-474X-2020-S1-9-120
  46. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. doi: 10.1016/S2213-2600(20)30076-X
  47. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. doi: 10.1016/S2213-2600(20)30079-5
  48. Vitacca M, Carone M, Clini EM, et al. Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper. Respiration. 2020;99(6):493-9. doi: 10.1159/000508399
  49. Thomas P, Baldwin C, Bissett B, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73-82. doi: 10.1016/j.jphys.2020.03.011
  50. Ohtake PJ, Lee AC, Scott JC, et al. Physical Impairments Associated With Post-Intensive Care Syndrome: Systematic Review Based on the World Health Organization’s International Classification of Functioning, Disability and Health Framework. Phys Ther. 2018;98(8):631-45. doi: 10.1093/ptj/pzy059
  51. Белкин А.А., Авдюнина И.А., Варако Н.А., и др. Реабилитация в интенсивной терапии. Клинические рекомендации. Вестник восстановительной медицины. 2017;2(78):139-43 [Belkin AA, Avdiunina IA, Varako NA, et al. Reabilitatsiia v intensivnoi terapii. Klinicheskie rekomendatsii. Vestnik vosstanovitel’noi meditsiny. 2017;2(78):139-43 (in Russian)].
  52. Herridge MS, Moss M, Hough CL, et al. Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Care Med. 2016;42(5):725-38. doi: 10.1007/s00134-016-4321-8
  53. Carda S, Invernizzi M, Bavikatte G, et al. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Ann Phys Rehabil Med. 2020;63(6):554-6. doi: 10.1016/j.rehab.2020.04.001
  54. National Institute for Health and Care Excellence. NICE & SIGN announce latest rapid Covid-19 guideline will address long Covid. Oct 5, 2020. Available at: https://www.nice.org.uk/news/article/nice-sign-announce-latest-rapid-covid-19-guideline-will-address-long-covid Accessed: 10.12.2020.
  55. Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324(6):603-5. doi: 10.1001/jama.2020.12603
  56. Perrin R, Riste L, Hann M, et al. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. doi: 10.1016/j.mehy.2020.110055
  57. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. Available at: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflong-covidsymptoms andcovid19complications. Accessed: 16.12.2020.
  58. Vaes AW, Machado FVC, Meys R, et al. Care Dependency in Non-Hospitalized Patients with COVID-19. J Clin Med. 2020;9(9):2946. doi: 10.3390/jcm9092946
  59. Временные методические рекомендации. Медицинская реабилитация при новой коронавирусной инфекции (COVID-19). Версия 2 (31.07.2020). Министерство здравоохранения Российской Федерации. Режим доступа: https://xn--80aesfpebagmfblc0a.xn--p1ai/ai/doc/461/attach/28052020_Preg_COVID-19_v1.pdf. Ссылка активна на 20.03.2021 [Temporary guidelines for medical rehabilitation for new coronavirus infection (COVID-19). Version 2 (31.07.2020) of the Ministry of health of the Russian Federation. Available at: https://xn--80aesfpebagmfblc0a.xn--p1ai/ai/doc/461/attach/28052020_Preg_COVID-19_v1.pdf. Accessed: 20.03.2021 (in Russian)].
  60. Simpson R, Robinson L. Rehabilitation After Critical Illness in People With COVID-19 Infection. Am J Phys Med Rehabil. 2020;99(6):470-4. doi: 10.1097/PHM.0000000000001443
  61. Tingbo L, Hongliu C, Yu C, et al. Handbook of COVID-19. Prevention and Treatment. 2020. Available at: http://education.almazovcentre.ru/wp-content/uploads/2020/03/Spravochnik_po_profilaktike_i_lecheniju_COVID_19.pdf. Accessed: 20.03.2021.
  62. Zhao HM, Xie YX, Wang C. Chinese Association of Rehabilitation Medicine, Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine Rehabilitation. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl). 2020;133(13):1595-602. doi: 10.1097/CM9.0000000000000848
  63. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-44. doi: 10.1164/rccm.2107138
  64. Centers for Disease Control and Prevention. Ending Home Isolation for Persons with COVID-19 Not in Healthcare Settings (Interim Guidance). 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html. Accessed: 20.03.2021.
  65. Cheng YY, Chen CM, Huang WC, et al. Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation. J Formos Med Assoc. 2021;120(1):83-92. doi: 10.1016/j.jfma.2020.08.015
  66. Yang LL, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Dis Transl Med. 2020;6(2):79-86. doi: 10.1016/j.cdtm.2020.05.002
  67. Авдеев С.Н., Царева Н.А., Мержоева З.М., и др. Практические рекомендации по кислородотерапии и респираторной поддержке пациентов с COVID-19 на дореанимационном этапе. Пульмонология. 2020;30(2):151-63 [Avdeev SN, Tsareva NA, Merzhoeva ZM, et al. Practical guidelines for oxygen therapy and respiratory support for patients with COVID-19 in the pre-life support. Pul’monologiya. 2020;30(2):151-63 (in Russian)]. doi: 10.18093/0869-0189-2020-30-2-151-163
  68. Liang T. Handbook of COVID-19. Prevention and Treatment. The First Affiliated Hospital, Zhejiang University School of Medicine. 2020;1-60. Available at: https://esge.org/documents/Handbook_of_COVID-19._Prevention_and_Treatment.pdf. Accessed: 20.03.2021
  69. Felten-Barentsz KM, van Oorsouw R, Klooster E, et al. Recommendations for Hospital-Based Physical Therapists Managing Patients With COVID-19. Phys Ther. 2020;100(9):1444-57. doi: 10.1093/ptj/pzaa114
  70. Мещерякова Н.Н., Белевский А.С., Кулешов А.В. Легочная реабилитация пациентов, перенесших коронавирусную инфекцию COVID-19 (клинические примеры). Пульмонология. 2020;30(5):715-22 [Meshcheryakova NN, Belevsky AS, Kuleshov AV. Pulmonary rehabilitation of patients with coronavirus infection COVID-19, clinical examples. Pul’monologiya. 2020;30(5):715-22 (in Russian)]. doi: 10.18093/0869-0189-2020-30-5-715-722
  71. Edwards AM, Wells C, Butterly R. Concurrent inspiratory muscle and cardiovascular training differentially improves both perceptions of effort and 5000 m running performance compared with cardiovascular training alone. Br J Sports Med. 2008;42(10):823-7. doi: 10.1136/bjsm.2007.045377
  72. Enright SJ, Unnithan VB, Heward C, et al. Effect of high-intensity inspiratory muscle training on lung volumes, diaphragm thickness, and exercise capacity in subjects who are healthy. Phys Ther. 2006;86(3):345-54. doi: 10.2522/ptj.2007.87.2.224
  73. Geddes EL, O’Brien K, Reid WD, et al. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med. 2008;102(12): 1715-29. doi: 10.1016/j.rmed.2008.07.005
  74. Gosselink R, De Vos J, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011;37(2):416-25. doi: 10.1183/09031936.00031810
  75. Severin R, Arena R, Lavie CJ, et al. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation. Am J Med. 2020;133(9):1025-32. doi: 10.1016/j.amjmed.2020.04.003
  76. Zhou L, Liu HG. Early detection and disease assessment of patients with novel coronavirus pneumonia. Chinese J tuberculosis and respiratory disease. 2020;43(3):167-70. doi: 10.3760/cma.j.issn.1001-0939.2020.0003
  77. Bissett B, Gosselink R, van Haren FMP. Respiratory Muscle Rehabilitation in Patients with Prolonged Mechanical Ventilation: A Targeted Approach. Crit Care. 2020;24(1):103. doi: 10.1186/s13054-020-2783-0
  78. KNGF position statement. Recommendations for physiotherapy in patients with COVID-19. Amersfoort, Netherlands: Royal Dutch Society for Physiotherapy (KNGF), 2020. Available at: https://www.kngf2.nl/binaries/content/assets/kennisplatform/onbeveiligd/guidelines/recommendations-for-physiotherapy-in-patients-with-covid-19---kngf.pdf. Accessed: 20.03.2021.
  79. Макарова М.Р., Лямина Н.П., Сомов Д.А., и др. Физическая реабилитация при пневмонии, ассоциированной с COVID-19. Учебно-методическое пособие. Москва, 2020 [Makarova MR, Lyamina NP, Somov DA, et al. Physical rehabilitation for СOVID-19 associated pneumonia. Teaching guide. Moscow, 2020 (in Russian)].
  80. Attaway A, Hatipoğlu U. Management of patients with COPD during the COVID-19 pandemic. Cleve Clin J Med. 2020. doi: 10.3949/ccjm.87a.ccc007
  81. Бубнова М.Г., Персиянова-Дуброва А.Л., Лямина Н.П., Аронов Д.М. Реабилитация после новой коронавирусной инфекции (COVID-19): принципы и подходы. CardioСоматика. 2020;11(4):6-14 [Bubnova MG, Persiyanova-Dubrova AL, Lyamina NP, Aronov DM. Rehabilitation after New Coronavirus Infection (COVID-19): principles and approaches. Cardiosomatics. 2020;11(4):6-14 (in Russian)]. doi: 10.26442/22217185.2020.4.200570
  82. Иванова Г.Е., Шмонин А.А., Мальцева М.Н., и др. Реабилитационная помощь в период эпидемии новой коронавирусной инфекции COVID-19 на первом, втором и третьем этапах медицинской реабилитации. Физическая и реабилитационная медицина, медицинская реабилитация. 2020;2(2):98-117 [Ivanova GE, Shmonin AA, Maltseva MN, et al. Rehabilitation Care During the New COVID-19 Coronavirus Infection Epidemic at First, Second and Third Medical Rehabilitation Phases. Physical and rehabilitation medicine, medical rehabilitation. 2020;2(2):98-117 (in Russian)]. doi: 10.36425/rehab34148
  83. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59. doi: 10.1249/MSS.0b013e318213fefb
  84. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020;2047487320913379. doi: 10.1177/2047487320913379
  85. Spruit MA, Singh SJ, Garvey C, et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST
  86. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17-96. doi: 10.1093/eurheartj/ehaa605
  87. Jones CJ, Rikli RE. Measuring functional fitness of older adults. J Active Aging. 2002;March-April:24-30.
  88. Briand J, Behal H, Chenivesse C, et al. The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease. Ther Adv Respir Dis. 2018;12:1-10. doi: 10.1177/1753466618793028
  89. Bohannon RW, Wang YC, Gershon RC. Two-minute walk test performance by adults 18 to 85 years: normative values, reliability, and responsiveness. Arch Phys Med Rehabil. 2015;96(3):472-7. doi: 10.1016/j.apmr.2014.10.006
  90. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-46. doi: 10.1183/09031936.00150314
  91. Haas F, Sweeney G, Pierre A, et al. Validation of a 2 Minute Step Test for Assessing Functional Improvement. Open J Ther Rehabil. 2017;5(2):71-81. doi: 10.4236/ojtr.2017.52007
  92. Coquart JB, Lemaître F, Castres I, et al. Reproducibility and Sensitivity of the 6-Minute Stepper Test in Patients with COPD. COPD. 2015;12(5):533-8. doi: 10.3109/15412555.2014.974733
  93. Бубнова М.Г., Аронов Д.М. Обеспечение физической активности граждан, имеющих ограничения в состоянии здоровья. Методические рекомендации. Под ред. С.А. Бойцова. CardioСоматика. 2016;7(1):5-50 [Bubnova MG, Aronov DM. Maintaining physical activity of those with limitations in health. Methodic recommendations. Edited by S.A. Boytsov. Cardiosomatics. 2016;7(1):5-50 (in Russian)]
  94. Аронов Д.М., Бубнова М.Г., Барбараш О.Л., и др. Национальные российские рекомендации по острому инфаркту миокарда с подъемом сегмента ST электрокардиограммы: реабилитация и вторичная профилактика. Рос. кардиол. журн. 2015;20(1):6-52 [Aronov DM, Bubnova MG, Barbarash OL, et al. Acute ST elevation myocardial infarction: rehabilitation and secondary prevention. National Russian Guidelines. Russian Journal of Cardiology. 2015;20(1):6-52 (in Russian)]. doi: 10.15829/1560-4071-2015-1-6-52
  95. Бокерия Л.А., Аронов Д.М., Бубнова М.Г., и др. Российские клинические рекомендации. Коронарное шунтирование больных ишемической болезнью сердца: реабилитация и вторичная профилактика. CardioСоматика. 2016;7(3-4):5-71 [Bokeriya LA, Aronov DM, Bubnova MG, et al. Russian clinical guidelines Coronary artery bypass grafting in patients with ischemic heart disease: rehabilitation and secondary prevention. Cardiosomatics. 2016;7(3-4):5-71 (in Russian)]
  96. Bartlo P, Bauer N. Pulmonary Rehabilitation Post-Acute Care for Covid-19. Available at: https://youtu.be/XjY_7O3Qpd8. Accessed: 20.03.2021.
  97. Martorella G, Fredericks S, Sanders J, Wynne R. Breaking pandemic chain reactions: telehealth psychosocial support in cardiovascular disease during COVID-19. Eur J of Cardiovasc Nurs. 2021;20:1-2. doi: 10.1093/eurjcn/zvaa011
  98. Barazzoni R, Bischoff SC, Breda J, et al. Endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631-8. doi: 10.1016/j.clnu.2020.03.022
  99. Гречко А.В., Евдокимов Е.А., Котенко О.Н., и др. Нутритивная поддержка пациентов с коронавирусной инфекцией COVID-19. Клиническое питание и метаболизм. 2020;1(2):56-91 [Grechko AV, Evdokimov EA, Kotenko ON, et al. Nutritional Support for Patients with COVID-19 Coronavirus Infection. Clinical nutrition and metabolism. 2020;1(2):56-91 (in Russian)]. doi: 10.36425/clinnutrit42278
  100. Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus: The species and its viruses, a statement of the Coronavirus Study Group. 2020. Available at:https://www.researchgate.net/publication/339441746_Severe_acute_respiratory_syndrome-related_coronavirus_The_species_and_its_viruses_-a_statement_of_the_Coronavirus_Study_Group. Accessed: 20.03.2021.
  101. Martindale R, Patel JJ, Taylor B, et al. Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care. Available at: https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/COVID19/Nutrition%20Therapy%20in%20the%20Patient%20with%20COVID-19%20Disease%20Requiring%20ICU%20Care_Updated%20May%2026.pdf. Accessed: 01.04.2020.
  102. Пасечник И.Н. Нутритивная поддержка больных коронавирусной инфекцией в критических состояниях. Анестезиология и реаниматология. 2020;3:70-5 [Pasechnik IN. Nutritional Support for Critically Ill Patients with coronavirus infection. Russian Journal of Anaesthesiology and Reanimatology. 2020;3:70-5 (In Russian)]. doi: 10.17116/anaesthesiology202003170
  103. Critical Care Specialist Group (CCSG) of the BDA Guidance on management of nutrition and dietetic services during the COVID-19 pandemic. Version 1.4 - 31/03/2020. Available at: https://www.bda.uk.com/uploads/assets/f5215258-7a34-4426-83620ba89f87c638/63decf82-db85-41d7-b5a6cbabe757a4a2/CCSG-Guidance-for-COVID-19-Formatted.pdf. Accessed: 01.04.2020.
  104. Приказ Минздрава России от 05.08.2003 N330 (с поправками от 24.11.2016) «О мерах по совершенствованию лечебного питания в лечебно-профилактических учреждениях Российской Федерации». Приказ Минздрава России от 05.05.2016 N279н «Об утверждении порядка организации санаторно-курортного лечения». Режим доступа: https://www.base.garant.ru. Ссылка активна на 01.04.2020 [Order of the Ministry of Health of the Russian Federation from 05.08.2003 N330 (as amended on 24.11.2016) “On measures to improve medical nutrition in medical institutions of the Russian Federation”. Order of the Ministry of Health of the Russian Federation from 05.05.2016 N279n “On the approval of the order of the organization of spa treatment”. Available at: https://www.base.garant.ru. Accessed: 01.04.2020 (in Russian)].
  105. Wang TJ, Chau B, Lui M, et al. Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769-74. doi: 10.1097/PHM.0000000000001505.

Copyright (c) 2021 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies